Search Results - "Radovancevic, R."

Use of Antihypertensive Medications in Left Ventricular Assist Device Patients Who Undergo Sleeve Gastrectomy by Jumean, M., Patel, A., Nathan, S., Kumar, S., Akay, M., de Armas, I. Salas, Patel, M., Rajagopal, K., Radovancevic, R., Gregoric, I., Kar, B.

“…The use of antihypertensive medications has been shown to significantly decrease in most morbidly obese patients who undergo sleeve gastrectomy (SG) surgery,…”
Get full text

Transcatheter Aortic Valve Replacement Management of Aortic Insufficiency in Patients with Left Ventricular Assist Device Support by Kar, B, Prathipati, P, Macedo, F.Y, Nathan, S, Radovancevic, R, Loyalka, P, Gregoric, I.D

Get full text

Post-Transplant Survival of Morbidly Obese LVAD Patients Undergoing Bariatric Surgery by Akay, M., Alagoz, M., Ng, M., de Armas, I.A. Salas, Jezovnik, M.K., Patel, M.K., Rajagopal, K., Kumar, S., Jumean, M., Akkanti, B.H., Radovancevic, R., Shah, S., Bajwa, K.S., Kar, B., Gregoric, I.D.

“…Patients with left ventricular assist devices (LVADs) who are morbidly obese cannot be easily bridged to heart transplantation (HT). Reported UNOS data show…”
Get full text

Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome by Bracey, A.W., Radovancevic, R., Riggs, S.A., Houston, S., Cozart, H., Vaughn, W.K., Radovancevic, B., McAllister Jr, H.A., Cooley, D.A.

“…BACKGROUND: There is controversy regarding the application of transfusion triggers in cardiac surgery. The goal of this study was to determine if lowering the…”
Get full text

The Role of Ventricular Reconditioning in Weaning From Continuous-Flow Ventricular Assist Devices by Frazier, O.H, Demirozu, Z.T, Mallidi, H.R, Segura, A.M, Hernandez, R, Radovancevic, R, Taegtmeyer, H, Cohn, W.E

Get full text

381 Morphologic Changes in the Aortic Wall after Support with a Nonpulsatile-Flow Left Ventricular Assist Device by Segura, A.M, Gregoric, I, Radovancevic, R, Demirozu, Z, Buja, L.M, Frazier, O.H

Get full text

744 Variability in Fibrosis of Tissue Samples Obtained after Diaphragmatic and Apical LVAD Implantation by Segura, A.M, Gregoric, I, Radovancevic, R, Aguayo, A, Buja, L.M, Frazier, O.H

Get full text

762 Use of Sealed Grafts in the HeartMate II Inflow and Outflow Conduits by Gregoric, I, Radovancevic, R, Patel, M, Fenik, L, Cohn, W, Frazier, O.H

Get full text

743 Role of Echocardiographic Assessment in Staged Weaning and Elective Removal of the HeartMate II LVAD by Frazier, O.H, Radovancevic, R, Demirozu, Z, Segura, A.M, Bogaev, R, Cohn, W, Gregoric, I

Get full text

558: The Effect of Continuous, Nonpulsatile Flow on Renal Function in Patients Supported by the HeartMate II Left Ventricular Assist Device by Demirozu, Z.T, Radovancevic, R, Frazier, O.H

Get full text

110 HeartMate II Left Ventricular Assist Device Inflow Cannula Implantation: Apical Versus Diaphragmatic Approach by Demirozu, Z.T, Radovancevic, R, Cohn, W.E, Gregoric, I.D, Frazier, O.H

Get full text

113 Subcostal/Extraperitoneal Versus Thoracotomy Implantation of the Jarvik 2000 Left Ventricular Assist Device in Patients with Previous Heart Surgery by Borovic, S, Demirozu, Z.T, Radovancevic, R, Gregoric, I.D, Frazier, O.H

Get full text

784 Clinical Experience with Patients over Age 65 Who Undergo HeartMate II LVAD Placement for Destination Therapy by Bruckner, B.A, Loebe, M, Estep, J.D, Motomura, T, Gregoric, I, Cohn, W.E, Radovancevic, R, Bunge, R.R, Frazier, O.H

Get full text

459: Positive Flow Cytometery Crossmatches and HLA Antibodies May Not Be Contraindications to Heart Transplantation by Kerman, R.H, Radovancevic, R, Allison, P.A, McKissick, E, Bogaev, R, Bracey, A.W, Allison, S, Gregoric, I, Frazier, O.H

Get full text

284: Improved quality of life and functional improvement in patients supported with the HeartMate II, an axial flow left ventricular assist device by Gemmato, C, Radovancevic, B, Carranza, S, Radovancevic, R, Delgado, R.M, Gregoric, I, Frazier, O.H

Get full text

88: Significance of anemia in patients undergoing long-term LVAD support by Vrtovec, B, Radovancevic, R, Delgado, R.M, Radovancevic, B, Bracey, A.W, Gregoric, I.D, Frazier, O.H

Get full text

Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients by Vrtovec, B, Thomas, C D, Radovancevic, R, Frazier, O H, Radovancevic, B

“…We compared the use of intravenous ganciclovir and cytomegalovirus hyperimmune globulin (CMVIG) as a pre-emptive treatment for cytomegalovirus (CMV)-positive…”
Get more information

(470) - LVAD/Stem Cell Combination Therapy in Nonischemic Dilated Cardiomyopathy Patients: Proof-of-Concept Study by Vrtovec, B., Poglajen, G., Frljak, S., Zemljic, G., Cerar, A., Knezevic, I., Radovancevic, R., Jorde, U., Gregoric, I.

Get full text

545: Impact of pretransplant statin treatment on sensitization and crossmatch results of cardiac allograft recipients by Reverdin, S, Varughese, E, Radovancevic, R, Hoover, A, Tu, T, Hosek, K, Victor, B, Stepkowski, S, Radovancevic, B, Frazier, O, Kerman, R

Get full text

251: Clinical relevance of crossmatch results, HLA and non-HLA Ab antibodies for cardiac allograft recipients by Kerman, R, Stepkowski, S, Hoover, A, Tu, T, Hosek, K, Victor, B, Reverdin, S, Varughese, E, Radovancevic, R, Frazier, O, Radovancevic, B

Get full text